Current Opinion in Oncology

Article	Citations
Lung cancer in China: current and prospect	179
Models of supportive care in oncology	47
BRAF mutations in thyroid cancer	42
Viral strategies for circumventing p53: the case of severe acute respiratory syndrome coronavirus	33
Malignant pleural mesothelioma: recent developments	32
Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis	29
T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities	24
Sinonasal cancers treatments: state of the art	24
Resistance mechanisms to osimertinib and emerging therapeutic strategies in nonsmall cell lung cancer	22
Targeting SUMOylation in cancer	22
The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma	19
Updated concepts in treatment of giant cell tumor of bone	18
MEK inhibitors in RASopathies	18
Management of epilepsy in brain tumor patients	18
Targeted radionuclide therapy: an emerging field in solid tumours	17
Immunotherapy and breast cancer: an overview	17
Geriatric assessments and frailty scores in multiple myeloma patients: a needed tool for individualized treatment?	16
Next-generation sequencing for the management of sarcomas with no known driver mutations	16
Adjuvant therapy of operable nonsmall cell lung cancer: an update	14
Triplet combination of BRAF, MEK and PD-1/PD-L1 blockade in melanoma: the more the better?	14
The role of the tumor matrix environment in progression of head and neck cancer	14
Adrenocortical carcinoma: current treatment options	13
Image-guided surgery in oral cancer: toward improved margin control	13
Targeting the methionine−methionine adenosyl transferase 2A−S-adenosyl methionine axis for cancer therapy	13
The evolving treatment paradigm of advanced hepatocellular carcinoma: putting all the pieces back together	13

Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapy	13
Retroperitoneal sarcoma: the Transatlantic Australasian Retroperitoneal Sarcoma Working Group Program	13
Interventions addressing fear of cancer recurrence: challenges and future perspectives	12
Harnessing dendritic cells for innovative therapeutic cancer vaccines	12
Novel immunotherapeutic drugs for the treatment of lung cancer	12
Treatment updates on tenosynovial giant cell tumor	12
T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA	12
Integrating new oral selective oestrogen receptor degraders in the breast cancer treatment	12
EBV-associated NK and T-cell lymphoid neoplasms	11
Mitogen-activating protein kinase pathway alterations in Langerhans cell histiocytosis	11
Systemic treatment of metastatic squamous cell carcinoma of the head and neck: proposal for management changes	11
An update on adult forms of hereditary pheochromocytomas and paragangliomas	11
New perspectives on targeting RAF, MEK and ERK in melanoma	10
Preoperative immunotherapy for head and neck cancers: state of art	10
Perspectives in pathomics in head and neck cancer	10
Bromodomain and extraterminal domain protein bromodomain inhibitor based cancer therapeutics	10
Primary vitreoretinal lymphoma: short review of the literature, results of a European survey and French guidelines of the LOC network for diagnosis, treatment and follow-up	10
Immunomodulation for hepatocellular carcinoma therapy: current challenges	9
Recent advances in primary resistance mechanisms against immune checkpoint inhibitors	9
Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment	9
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers	9
Is less more in the surgical treatment of early-stage cervical cancer?	9
Understanding the tumor-immune microenvironment in prostate cancer	8
Prognostic factors in primary central nervous system lymphoma	8
New molecular entities of soft tissue and bone tumors	8
Desmoid tumors: who, when and how to treat?	8
Biomarkers and immunotherapy: where are we?	8
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy	8
Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy	8
Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia	8
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations	7
COVID-19 and supportive cancer care: key issues and opportunities	7
Bacterial infection-driven lymphomagenesis	7
Lung cancer screening: a critical appraisal	7
Antibodies targeting Prostate-Specific Membrane Antigen positive prostate cancer: from diagnostic imaging to theranostics	7
The road to chemotherapy-free treatment in chronic lymphocytic leukaemia	7
Adjuvant and neoadjuvant approaches in pancreatic cancer	7
Tyrosine kinase inhibitors as induction therapy in nonsmall-cell lung cancer	7
Mutational burden and immune recognition of gliomas	7
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer	7
Transcriptional and epigenetic control of early life cell fate decisions	6
Targeting cancer stem cell pathways for lung cancer therapy	6
Renal oncocytoma: a challenging diagnosis	6
The role of autologous stem-cell transplantation in multiple myeloma in 2021	6
Supportive care for new cancer therapies	6
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	6
Challenges adopting next-generation sequencing in community oncology practice	6
New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions	6
Desmoid-type fibromatosis: toward a holistic management	6
Hairy cell leukemia: a brief update on current knowledge and treatment prospects	6

What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma?	6
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review	6
Emerging systemic antitarget treatment for differentiated thyroid carcinoma	6
Epstein-Barr virus-associated posttransplant lymphoproliferative disorders: new insights in pathogenesis, classification and treatment	6
Current treatments of medulloblastoma	6
Artificial intelligence: opportunities in lung cancer	5
Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019–2021	5
New perspectives in liquid biopsy for glioma patients	5
Ten steps to establish a national centre for gestational trophoblastic disease	5
Question prompt lists to improve communication between cancer patients and healthcare professionals	5
The multiple molecular dimensions of long noncoding RNAs that regulate gene expression and tumorigenesis	5
Advances in myelodysplastic syndrome	5
Ovarian preservation in gynecologic oncology: current indications and techniques	5
A challenging frontier – the genomics and therapeutics of nonclear cell renal cell carcinoma	5
Educational needs of self-care in cachectic cancer patients and caregivers	5
The evolving treatment landscape of advanced urothelial carcinoma	5
Psycho-oncology interventions focusing on fatigue and sleep disturbances	5
Highlighting recent treatment advances in metastatic prostate cancer: expanding the treatment arsenal	5
Immunotherapy of sarcomas with modified T cells	5
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	5
The role of next-generation sequencing in acute myeloid leukemia	5
Tropomyosin receptor kinases in sarcomas – of joy and despair	5
Immunotherapy combinations in advanced nonsmall cell lung cancer	5
Angiogenesis inhibition in lung cancer: emerging novel strategies	5
New treatments for desmoid tumors	4
Pediatric brain tumors as a developmental disease	4
Mitogen-activated protein kinase blockade in melanoma: intermittent versus continuous therapy, from preclinical to clinical data	4
The changing landscape for patients with relapsed/refractory acute myeloid leukaemia	4
Active surveillance in favorable intermediate risk prostate cancer: outstanding questions and controversies	4
Melanoma with genetic alterations beyond the BRAF V600 mutation: management and new insights	4
Use of staging for sex cord stromal tumours	4
Importance of guidelines and networking for the management of rare gynecological cancers	4
Postneoadjuvant treatment for triple-negative breast cancer	4
HTLV-1-related adult T-cell leukemia/lymphoma: insights in early detection and management	4
New treatments in advanced gastrointestinal stromal tumor	4
The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy	4
Pathology and new insights in central nervous system lymphomas	4
Novel next-generation sequencing-based methodologies to characterize the mutational consequences of (prenatal) chemotherapy exposure in noncancerous tissue	4
Next questions for the medical treatment of gastrointestinal stromal tumor	4
MAPK blockade, toxicities, pathogenesis and management	4
CIC-DUX4 sarcomas	4
Nanoparticle therapy for head and neck cancers	4
Emerging role of multiparametric magnetic resonance imaging in identifying clinically relevant localized prostate cancer	4
Neoadjuvant immunotherapy in nonsmall cell lung cancer	4
New developments in rare vulvar and vaginal cancers	4
Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers	4
Oral microbiome as a new research-target for supportive care and precision oncology	4
New targeted treatments for advanced sarcomas	4
Pathology and new insights in thyroid neoplasms in the 2022 WHO classification	4
Treatment of small cell lung cancer: recent advances	3
Venetoclax in combination with nucleoside analogs in acute myelogenous leukemia	3
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)	3
Treatment of anaplastic gliomas: evidences and controversies	3
How to support parenting in patients with cancer and co-parents? From research to practice	3
Targeting exon 20 insertion mutations in lung cancer	3
Maintenance therapies in acute myeloid leukemia: the renaissance of an old therapeutic concept	3
State of the art and future directions in the systemic treatment of neuroendocrine neoplasms	3
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update	3
Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer	3
Systemic treatment of recurrent and/or metastatic squamous cell carcinomas of the head and neck: what is the best therapeutic sequence?	3
Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer	3
Surgical management of skull base meningiomas and vestibular schwannomas	3
How to prevent human papillomavirus-related oropharyngeal cancer?	3
Novel treatment approaches for HER2 positive solid tumors (excluding breast cancer)	3
Breast surgery after neoadjuvant therapy	3
Early Detection of Cancers in the Era of Precision Oncology	3
HHV-8 associated lymphoma	3
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas	3
Editorial: Lung cancer: continuous progress in diagnosis and treatment	3
HIV-related lymphomas	3
Management of metastatic melanoma with new immunotherapy approaches beyond PD-1/CTLA-4 inhibitors	3
Kirsten rat sarcoma inhibitors in clinical development against nonsmall cell lung cancer	3
Recent advances in radiosensitivity determinants in melanoma	3
New horizons in early drugs development in solid cancers	3
State of the art and future directions in the systemic treatment of medullary thyroid cancer	3
Editorial: The challenge of treating and investigating rare gynaecologic cancers	3
Unveiling the enigma of the blood–brain barrier in glioblastoma: current advances from preclinical and clinical studies	3
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer: is there a role?	3
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine	3
Fasting-mimicking diet: a metabolic approach for the treatment of breast cancer	3

Immunotherapy in rare ovarian cancer	3
Clinical management of brain tumors in pregnancy	3
Advance care planning in oncology: a scoping review and some recommendations	3
Immunotherapies in non-metastatic gastrointestinal cancers	3
Evolving systemic management of urothelial cancers	2
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	2
Postmastectomy radiotherapy: a review	2
Neoadjuvant chemotherapy for patients with locally advanced vulvar cancer	2
Oligometastatic disease from differentiated thyroid cancer: best treatment schemes	2
Advances in management of nonendometrioid endometrial carcinoma, with an emphasis on the sentinel lymph node technique	2
The conquest of lung cancer in Central Europe	2
Improved guideline adherence in oncology through clinical decision-support systems: still hindered by current health IT infrastructures?	2
Advances in testing for human papillomavirus-mediated head and neck cancer	2
Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma	2
Pathologic diagnosis of lung cancer – recent developments	2
Circulating tumor DNA in breast cancer: a biomarker for patient selection	2
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	2
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?	2
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer	2
Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials	2
Management of small bowel adenocarcinoma: making the most of the available evidence to inform routine practice	2
The role of Fusobacteria in oral cancer and immune evasion	2
Interventions for children of parents with cancer: an overview	2
Surrogate endpoints for HTA decisions of breast cancer drugs: utility and pitfalls	2
Current “state of the art” on dendritic cell-based cancer vaccines in melanoma	2
Genetic testing in patients with triple-negative or hereditary breast cancer	2
Update on bi-specific monoclonal antibodies for blood cancers	2
High-risk, recurrent and oligometastatic prostate cancer: recent developments on the role of radiation	2
The role and underlying mechanisms of tumour-derived exosomes in lung cancer metastasis	2
Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma	2
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence	2
Advances in the treatment of light chain amyloidosis	2
First and further-line multidisciplinary treatment of retroperitoneal sarcomas	2
The impact of new and emerging agents on outcomes for febrile neutropenia: addressing clinical gaps	2
Highlighting recent progress in the treatment of men with advanced prostate cancer	2
Next questions in the management of retroperitoneal sarcoma	2
Rare driver alterations in nonsmall cell lung cancer: novel targeted drugs	2
Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?	2
Congenital vascular lesions, could MAPK and PI3K inhibitors pave the way to new therapies?	2
Unveiling the role of cellular dormancy in cancer progression and recurrence	2
Mind the target: circulating tumour DNA in gastrointestinal malignancies	2
Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	2
Current treatment options for nodular lymphocyte-predominant Hodgkin lymphoma	2
Recent advances in allogeneic transplantation for acute myeloid leukemia	2
New boundaries for fertility sparing management in endometrial cancer	2